Dr. Vivek B. Pai MD

Recommended Articles

• Lemtrada Gains FDA Approval to Treat Multiple Sclerosis

  In the United States alone, over 400,000 individuals are dealing with the challenges associated with multiple sclerosis (MS). Most recently, Sanofi, an international leader in healthcare, announced FDA approval of the prescription drug Lemtrada, for the treatment of patients with relapsing forms of...

• Imperative Information on Benzodiazepines: Lorazepam vs. Xanax

  What is lorazepam?Lorazepam is an anti-anxiety medication that belongs to the benzodiazepine class. It is prescribed to treat anxiety disorders and acts on the central nervous system by providing a calming effect. Lorazepam is sold under different brand names, which include Ativan, Almazine,...

• Migraines and Nausea: What You Need to Know

  A lot of people are troubled by migraine headaches. It can be so intense that a person’s daily living can be affected. It’s not just the pain that makes migraines difficult to deal with. Migraines are also associated with nausea, which makes it more difficult and debilitating for some...

• Is My Child More Likely to Develop Autism if a Blood Relative Has Autism?

  Autism characterized by impaired social interactions reduced verbal and non-verbal communication and stereotyped behavior and activities. These symptoms appear in early childhood and impair or limit everyday functioning.Autism and geneticsResearchers believe that both environment and genetics play a...

• Treatment for Meningitis

  The severity of meningitis varies from one person to another. In common cases, medications can help solve the problem and the person may recover within 1 to 3 weeks. But in cases where there is a risk of the infection spreading to the meninges, hospitalization and other confirmation tests might be...

• What is an Ocular Migraine?

  Ocular migraines, also known as retinal migraines, ophthalmic migraines, or monocular migraines, are characterized by visual disturbances that occur alongside or after migraine headaches. In this type, the person will have bouts of reduced vision or blindness that remains for a short period. In most...